ABEO

2.4201.22%
BM

Brendan M. O’Malley

Chief Legal Officer

Dr. Brendan M. O’Malley, J.D & Ph.D., serves as Chief Legal Officer of Abeona Therapeutics Inc from 2025 and served as Senior Vice President and General Counsel at Abeona Therapeutics Inc since September 20, 2021 until 2025. In his role as General Counsel, Dr. O’Malley leverages his significant legal and technical expertise in the biotechnology industry to oversee legal, corporate, IP, compliance and other related matters for Abeona. He served as a Corporate Secretary at Abeona Therapeutics Inc. until September 2021. He served as Vice President and Head of Legal & IP at Abeona Therapeutics Inc. since 2020 until September 2021. Dr. O’Malley joined Abeona in May 2019 as Chief IP Counsel and was promoted to Head of Legal & IP in April 2020. Prior to joining Abeona, he was a partner at the prominent New York patent litigation firm Fitzpatrick Cella Harper & Scinto, where he started his career as a summer associate in 2006 and then at Venable LLP, which merged with Fitzpatrick in 2018. While at Fitzpatrick and Venable, Dr. O’Malley litigated a wide variety of biopharmaceutical patent cases in the United States District Courts, at the Federal Circuit and before the U.S. Patent and Trademark Office, negotiated numerous settlement and license agreements and provided many patent opinions in connection with M&A due diligence in the biotech space. While attending law school at Benjamin N. Cardozo School of Law, Dr. O’Malley served as a judicial intern to Judge William H. Pauley in the U.S. District Court for the Southern District of New York. Before law school, he earned a Ph.D. in Molecular Biology & Microbiology from Tufts University School of Medicine, where he studied the role of protein-protein interactions in hepatitis virus assembly and a B.S. degree magna cum laude from the University of Massachusetts Dartmouth.

公司职务